← brief for 2026-08-21 · Slowing decline

Effect of pentoxifylline on inflammatory markers in non-diabetic chronic kidney disease patients: A prospective, interventional, open label.

Article C Peer reviewed Observational

Key takeaways

In non-diabetic CKD patients, pentoxifylline reduced inflammation and protein in the urine. This was an open-label study with 30 patients followed for 12 weeks. It showed a link between reduced inflammation and slower kidney decline, but not proof of causality.

Who did this work

Abd El Mobdy AH · Hebah HA · Ezzat MA · Eid Mohamed BA · Ahmed FA

Source

Article · PubMed, Reducing protein and albumin in urine · 2026 Sep 25
https://pubmed.ncbi.nlm.nih.gov/42626272/